Hajer ben Brahim
Department of Infectious Diseases, University Hospital Fattouma Bourguiba, Monastir, TunisiaPublications
-
Case Report
Herpes Zoster involving the maxillary branch of the trigeminal nerve after viral vector COVID-19 vaccine: is it a possible adverse effect?
Author(s): Rebeh Bougossa47673*, Wafa Marrakchi47674, Ikbel Kooli47675, Hajer ben Brahim47676, Adnene Toumi47677, Abir Aouam47678 and Mohammed Chakroun47679
Introduction: Several vaccines against COVID-19 have been developed and approved. Many cases of Varicella-zoster virus reactivation following mRNA and inactivated COVID-19 vaccines have been described in the literature, suggesting a link between these vaccinations and the virus reactivation. However, reported cases of herpes zoster after viral vector COVID-19 vaccines were few. Case presentation: We report a case of a maxillary zoster in a 66 year-old immunocompetent female, occurring 5 days after the first dose of a viral vector COVID-19 vaccination. The patient was treated with intravenous acyclovir for 10 days with a favourable outcome. Conclusion: To the best of our knowledge, this is the first case of a maxillary zoster after viral vector COVID-19 vaccine. It may be a potential side effect of this vac.. Read More»
DOI: 10.31858/0975-8453.13.12.831-832
Abstract
How to cite this article